Chronic painful chemotherapy-induced polyneuropathy (Q101432): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 18:14, 16 August 2026
Chronic painful chemotherapy-induced polyneuropathy (CIPN) is chronic peripheral neuropathic pain caused by oral or intravenous chemotherapy given to treat the primary tumour or metastases. Pain may be the initial symptom of a neuropathy or develop over the course of the disease. The pain may be spontaneous or evoked, as an increased response to a painful stimulus (hyperalgesia) or a painful response to a normally nonpainful stimulus (allodynia). Negative (e.g., decreased or loss of sensation) and positive sensory symptoms or signs (e.g., allodynia or hyperalgesia) must be compatible with the anatomical distribution pattern of the polyneuropathy.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1299421977 |
||
| English | Chronic painful chemotherapy-induced polyneuropathy |
Chronic painful chemotherapy-induced polyneuropathy (CIPN) is chronic peripheral neuropathic pain caused by oral or intravenous chemotherapy given to treat the primary tumour or metastases. Pain may be the initial symptom of a neuropathy or develop over the course of the disease. The pain may be spontaneous or evoked, as an increased response to a painful stimulus (hyperalgesia) or a painful response to a normally nonpainful stimulus (allodynia). Negative (e.g., decreased or loss of sensation) and positive sensory symptoms or signs (e.g., allodynia or hyperalgesia) must be compatible with the anatomical distribution pattern of the polyneuropathy. |
Statements
CID11:ID_1299421977
0 references
dki-india-ID_1299421977
0 references
Concluído
0 references
15 August 2026
0 references
